文献速递中医内科中药与中成药合理使用

急性心肌梗死患者中药使用趋势:台湾十年队列分析

Utilization trends in traditional Chinese medicine for acute myocardial infarction.
PubMed 文献 · J Ethnopharmacol · 2019-06-05

基于台湾全民健康保险理赔数据库,抽取2000-2001年与2010-2011年两个急性心肌梗死(AMI)首发住院队列,比较出院后一年内接受中医治疗者的特征与处方模式。两队列接受中医治疗比例相似(20%与21%),最常见单味药均为丹参,但最常用复方由血府逐瘀汤变为炙甘草汤。

要点

  • 两队列AMI患者接受中医治疗比例相近,约五分之一。
  • 两个年代最常用单味中药均为丹参。
  • 最常用中药复方从血府逐瘀汤演变为炙甘草汤。

核心结论

  • 两个AMI队列的中药复方处方频率存在差异,提示十年间处方实践从时方向经方演变。

研究设计与样本

  • 横断面研究,使用台湾全民健康保险理赔数据库,从两个随机抽取的百万受益人样本中识别2000-2001年与2010-2011年首次因AMI住院的两个队列。

主要发现

  • 接受中医治疗的患者比例在两个AMI队列中相似:2000-2001年队列为20%(85/418),2010-2011年队列为21%(169/817)。
  • 在2010-2011年AMI队列中,中医使用者中男性比例小于非使用者,且高脂血症比例更低。
  • 两个队列中医使用者中最常处方的单味药均为丹参(Salvia miltiorrhiza Bunge)。
  • 2000-2001年队列最常用中药复方为血府逐瘀汤,2010-2011年队列为炙甘草汤。

临床怎么用

  • 研究提示AMI患者出院后使用中药时,丹参为最常用单味药,复方选择随时间从血府逐瘀汤转向炙甘草汤。
  • 临床可参考此趋势了解AMI恢复期中药处方模式的演变,但疗效影响尚需进一步研究。

局限性

  • 研究为横断面设计,无法评估中药使用变化对治疗效果的影响。
  • 原文未报告处方剂量、疗程及患者具体临床结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Among heart diseases, acute myocardial infarction (AMI) is the most serious and life-threatening emergency. In Taiwan, heart disease has consistently ranked second among the top 10 leading causes of death since 2007, second only to malignant tumors; however, population-based studies on the use of traditional Chinese medicine (TCM) in AMI cases are limited. AIM OF THE STUDY: This study investigated the characteristics of TCM users and prescriptions of TCM, and their differences between two cohorts of patients with AMI, identified 10 years apart. MATERIALS AND METHODS: A cross-sectional study was conducted using the Taiwan National Health Insurance claims database. From among two random sample of 1 million beneficiaries selected from the claims database, we identified two cohorts of patients with first hospitalization for AMI in between 2000-2001 and 2010-2011. Patients who had received TCM therapy within one year after hospital discharge were defined as TCM users, whereas, all the other patients with AMI were considered non-users of TCM. We compared the characteristics of TCM use and the patterns of prescriptions between the two cohorts. RESULTS: The proportion of patients receiving TCM care was similar between the two AMI cohorts; 20% (85/418) of the patients were diagnosed in 2000-2001 and 21% (169/817) in 2010-2011. In the 2010-2011 AMI cohort, the proportion of men was smaller among TCM users than non-users, and TCM users were less likely to have hyperlipidemia. Among TCM users, the most frequently prescribed herb was Dan-shen (Salvia miltiorrhiza Bunge, Salvia root) in both cohorts. The most commonly used Chinese herbal formulations were Xue-Fu-Zhu-Yu-Tang (Blood Mansion Dispel Stasis) for the 2000-2001 cohort and Zhi-Gan-Cao-Tang (Honey-Fried Licorice Decoction) for the 2010-2011 cohort. CONCLUSIONS: This study revealed the differences in the prescription frequency of Chinese herbal formulation among the two cohort of patients with AMI, suggesting that the practice of prescribing TCM has evolved from post-antique formula to classical remedies during the 10 years evaluated. Further investigations are needed to evaluate if the change in the utilization of Chinese herbal formulations impacts the effectiveness of the treatment.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Lu CY, Lu PC, Chen PC, et al. Utilization trends in traditional Chinese medicine for acute myocardial infarction. J Ethnopharmacol. 2019. PMID: 31175928. doi:10.1016/j.jep.2019.112010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。